Prolonged survival in adult neurofibromatosis type I patients with recurrent high-grade gliomas treated with bevacizumab. (Q48769865)

15 February 2018

title

Prolonged survival in adult neurofibromatosis type I patients with recurrent high-grade gliomas treated with bevacizumab. (English)

1 reference

15 February 2018

1 reference

neurofibromatosis type I

1 reference

2

Benjamin Ellezam

1 reference

15 February 2018

author name string

Brett J Theeler

1

1 reference

15 February 2018

Shlomit Yust-Katz

3

1 reference

15 February 2018

John M Slopis

4

1 reference

15 February 2018

Monica E Loghin

5

1 reference

15 February 2018

John F de Groot

6

1 reference

15 February 2018

publication date

25 May 2014

1 reference

15 February 2018

published in

Journal of Neurology

1 reference

15 February 2018

volume

261

1 reference

15 February 2018

issue

8

1 reference

15 February 2018

page(s)

1559-1564

1 reference

15 February 2018

https://scigraph.springernature.com/pub.10.1007/s00415-014-7292-0

exact match

0 references

cites work

NF1 gene and neurofibromatosis 1

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7292-0

Neoplasms associated with germline and somatic NF1 gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7292-0

Gliomas in neurofibromatosis type 1: a clinicopathologic study of 100 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7292-0

Neurofibromatosis type 1 and high-grade tumors of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7292-0

Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7292-0

Adenoid glioblastoma arising in a patient with neurofibromatosis type-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7292-0

Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7292-0

Transformation of intracranial anaplastic astrocytoma associated with neurofibromatosis type I into gliosarcoma: case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7292-0

FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7292-0

Cerebellar gliomas in children with NF1: pathology and surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7292-0

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7292-0

MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7292-0

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7292-0

Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7292-0

Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7292-0

Management of glioblastoma in an NF1 patient with moyamoya syndrome: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7292-0

Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7292-0

Association of rapidly progressive moyamoya syndrome with bevacizumab treatment for glioblastoma in a child with neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7292-0

Discovery of asymptomatic moyamoya arteriopathy in pediatric syndromic populations: radiographic and clinical progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7292-0

Glioblastoma multiforme in the posterior cranial fossa in a patient with neurofibromatosis type I.

21 January 2018

1 reference

12 December 2020

Cerebellar anaplastic astrocytoma in an adult with neurofibromatosis type 1: case report and review of literature

1 reference

12 December 2020

Heavily lipidized, calcified giant cell glioblastoma in an 8-year-old patient, associated with neurofibromatosis type 1 (NF1): report of a case with long-term survival.

1 reference

12 December 2020

Clinicopathologic study of glioblastoma in children with neurofibromatosis type 1.

1 reference

12 December 2020

10.1007/S00415-014-7292-0

Identifiers

DOI

1 reference

15 February 2018

PubMed ID

24859329

1 reference

15 February 2018